Galluzzi L - Search Results

1

NK cells and solid tumors: therapeutic potential and persisting obstacles.

Tong L, Jiménez-Cortegana C, Tay AHM, Wickström S, Galluzzi L, Lundqvist A. Tong L, et al. Among authors: galluzzi l. Mol Cancer. 2022 Nov 1;21(1):206. doi: 10.1186/s12943-022-01672-z. Mol Cancer. 2022. PMID: 36319998 Free PMC article. Review.

2

Quantitative assessment of mitophagy in irradiated cancer cells.

Guilbaud E, Spada S, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Aretz A, Buqué A, Yamazaki T, Demaria S, Galluzzi L. Guilbaud E, et al. Among authors: galluzzi l. Methods Cell Biol. 2023;174:93-111. doi: 10.1016/bs.mcb.2022.09.002. Epub 2022 Oct 30. Methods Cell Biol. 2023. PMID: 36710054

3

Myeloid-derived suppressor cells: Emerging players in cancer and beyond.

Jiménez-Cortegana C, Galluzzi L. Jiménez-Cortegana C, et al. Among authors: galluzzi l. Int Rev Cell Mol Biol. 2023;375:xiii-xix. doi: 10.1016/S1937-6448(23)00048-5. Int Rev Cell Mol Biol. 2023. PMID: 36967156 No abstract available.

4

T cell-independent abscopal responses to radiotherapy.

Guilbaud E, Yamazaki T, Galluzzi L. Guilbaud E, et al. Among authors: galluzzi l. Trends Cancer. 2023 Feb;9(2):93-95. doi: 10.1016/j.trecan.2022.12.005. Epub 2022 Dec 20. Trends Cancer. 2023. PMID: 36543690

5

Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors.

Klapp V, Buqué A, Bloy N, Sato A, Yamazaki T, Zhou XK, Formenti SC, Galluzzi L, Petroni G. Klapp V, et al. Among authors: galluzzi l. J Transl Med. 2023 Feb 10;21(1):110. doi: 10.1186/s12967-023-03964-4. J Transl Med. 2023. PMID: 36765430 Free PMC article.

6

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma.

Cultrara C, Uhl C, Kirby K, Abed Elrazaq E, Zellander A, Andrews DW, Scott CB, Galluzzi L, Exley MA, Zilberberg J. Cultrara C, et al. Among authors: galluzzi l. J Immunother Cancer. 2023 Aug;11(8):e006880. doi: 10.1136/jitc-2023-006880. J Immunother Cancer. 2023. PMID: 37550054 Free PMC article.

7

Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.

Pouget JP, Chan TA, Galluzzi L, Constanzo J. Pouget JP, et al. Among authors: galluzzi l. Trends Cancer. 2023 Nov;9(11):968-981. doi: 10.1016/j.trecan.2023.07.014. Epub 2023 Aug 21. Trends Cancer. 2023. PMID: 37612188 Review.

8

Interferon signaling restrains renal cell carcinoma heterogeneity.

Holicek P, Fucikova J, Galluzzi L. Holicek P, et al. Among authors: galluzzi l. Trends Cancer. 2023 Nov;9(11):871-873. doi: 10.1016/j.trecan.2023.08.008. Epub 2023 Aug 30. Trends Cancer. 2023. PMID: 37658022 Free PMC article.

9

Mitochondrial control of antigen presentation in cancer cells.

Soler-Agesta R, Anel A, Galluzzi L. Soler-Agesta R, et al. Among authors: galluzzi l. Cancer Cell. 2023 Nov 13;41(11):1849-1851. doi: 10.1016/j.ccell.2023.10.001. Epub 2023 Oct 26. Cancer Cell. 2023. PMID: 37890494

10

Immunogenicity of ferroptosis in cancer: a matter of context?

Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Catanzaro E, et al. Among authors: galluzzi l. Trends Cancer. 2024 May;10(5):407-416. doi: 10.1016/j.trecan.2024.01.013. Epub 2024 Feb 16. Trends Cancer. 2024. PMID: 38368244 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

629 results

Search Page